Apyx Medical Statistics
Total Valuation
Apyx Medical has a market cap or net worth of $167.32 million. The enterprise value is $171.46 million.
Important Dates
The last earnings date was Thursday, May 7, 2026, before market open.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Apyx Medical has 41.83 million shares outstanding. The number of shares has increased by 10.75% in one year.
| Current Share Class | 41.83M |
| Shares Outstanding | 41.83M |
| Shares Change (YoY) | +10.75% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 13.27% |
| Owned by Institutions (%) | 34.39% |
| Float | 30.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.92 |
| Forward PS | 2.70 |
| PB Ratio | 12.63 |
| P/TBV Ratio | 12.71 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.07 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.80, with a Debt / Equity ratio of 3.02.
| Current Ratio | 5.80 |
| Quick Ratio | 4.65 |
| Debt / Equity | 3.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.77 |
Financial Efficiency
Return on equity (ROE) is -76.49% and return on invested capital (ROIC) is -5.27%.
| Return on Equity (ROE) | -76.49% |
| Return on Assets (ROA) | -4.37% |
| Return on Invested Capital (ROIC) | -5.27% |
| Return on Capital Employed (ROCE) | -8.04% |
| Weighted Average Cost of Capital (WACC) | 11.58% |
| Revenue Per Employee | $272,702 |
| Profits Per Employee | -$44,727 |
| Employee Count | 205 |
| Asset Turnover | 0.91 |
| Inventory Turnover | 2.39 |
Taxes
In the past 12 months, Apyx Medical has paid $364,000 in taxes.
| Income Tax | 364,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +182.52% in the last 52 weeks. The beta is 1.35, so Apyx Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.35 |
| 52-Week Price Change | +182.52% |
| 50-Day Moving Average | 3.72 |
| 200-Day Moving Average | 3.31 |
| Relative Strength Index (RSI) | 56.19 |
| Average Volume (20 Days) | 238,555 |
Short Selling Information
The latest short interest is 221,167, so 0.53% of the outstanding shares have been sold short.
| Short Interest | 221,167 |
| Short Previous Month | 195,810 |
| Short % of Shares Out | 0.53% |
| Short % of Float | 0.74% |
| Short Ratio (days to cover) | 1.52 |
Income Statement
In the last 12 months, Apyx Medical had revenue of $55.90 million and -$9.17 million in losses. Loss per share was -$0.22.
| Revenue | 55.90M |
| Gross Profit | 35.30M |
| Operating Income | -4.31M |
| Pretax Income | -8.71M |
| Net Income | -9.17M |
| EBITDA | -3.59M |
| EBIT | -4.31M |
| Loss Per Share | -$0.22 |
Full Income StatementBalance Sheet
The company has $31.14 million in cash and $39.46 million in debt, with a net cash position of -$8.32 million or -$0.20 per share.
| Cash & Cash Equivalents | 31.14M |
| Total Debt | 39.46M |
| Net Cash | -8.32M |
| Net Cash Per Share | -$0.20 |
| Equity (Book Value) | 13.09M |
| Book Value Per Share | 0.31 |
| Working Capital | 45.35M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$7.87 million and capital expenditures -$1.12 million, giving a free cash flow of -$8.99 million.
| Operating Cash Flow | -7.87M |
| Capital Expenditures | -1.12M |
| Depreciation & Amortization | 719,000 |
| Net Borrowing | -20,000 |
| Free Cash Flow | -8.99M |
| FCF Per Share | -$0.21 |
Full Cash Flow StatementMargins
Gross margin is 63.15%, with operating and profit margins of -7.70% and -16.40%.
| Gross Margin | 63.15% |
| Operating Margin | -7.70% |
| Pretax Margin | -15.58% |
| Profit Margin | -16.40% |
| EBITDA Margin | -6.42% |
| EBIT Margin | -7.70% |
| FCF Margin | n/a |
Dividends & Yields
Apyx Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.75% |
| Shareholder Yield | -10.75% |
| Earnings Yield | -5.62% |
| FCF Yield | -5.51% |
Analyst Forecast
The average price target for Apyx Medical is $6.50, which is 62.50% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.50 |
| Price Target Difference | 62.50% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 46.88% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 6, 1994. It was a reverse split with a ratio of 1:15.
| Last Split Date | Jan 6, 1994 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |
